PHILADELPHIA — Three graduate students from the University of Pennsylvania have been selected as Medical Research Fellows by the Howard Hughes Medical Institute (HHMI). Ryan Kiefer and Richard Maduka from the Perelman School of Medicine, and Megan Clark from the School of Veterinary Medicine, are among the 66 medical and veterinary students chosen by the HHMI to spend a year in a laboratory working with a mentor on a biomedical research project that each student proposed.
Ryan Kiefer
Richard Maduka
Each medical fellow receives $41,000 in grant support, and fellows are eligible to apply for a second year in the program. The program allows participants a respite from their medicine or veterinary training to burnish their research skills, with an aim to produce physicians and veterinarians well versed in basic scientific research.
Ryan Kiefer is a medical student finishing his third year at the Perelman School of Medicine. Early in his medical education, he was introduced to the field of interventional radiology and became interested in both the clinical therapies and research performed by this specialty. Beginning this summer, he will take a year-long hiatus from his clinical education to perform basic and translational science research under the mentorship of Terence Gade, MD, PhD, an assistant professor of Radiology who is part of the Penn Image-Guided Intervention Laboratory. The PIGI Laboratory utilizes numerous methods to develop diagnostic and therapeutic approaches to various pathologies with a particular interest in oncologic therapy. Ryan will work with Gade to study the metabolic stress response of live cancer in an effort develop a novel imaging paradigm for dormant cancer states that may lead to improved detection and treatment of this condition and others like it. Following the completion of his research and final year of medical school, Ryan plans to pursue a residency and eventually a career in academic interventional radiology.
Richard Maduka, in his third year of medical school at the Perelman School of Medicine, has participated in several clinical research projects with the department of Surgery at the Hospital of the University of Pennsylvania and gained exposure to gastrointestinal medicine. He will now be taking the year to perform basic science research under the mentorship of Celeste Simon, PhD, a professor of cell and developmental biology, who runs her laboratory within the Abramson Family Cancer Research Institute. The Simon lab research focus is to elucidate the molecular mechanisms by which changes in oxygen and nutrient availability modulate normal tissue homeostasis and mammalian pathology, with a particular focus on cancer cell metabolic reprogramming, metastasis, and the link between chronic inflammation and cancer predisposition. Maduka will work with Simon to characterize the role of the HIF1-alpha gene and B lymphocytes in pancreatic cancer, and the mechanism by which these factors promote accelerated oncogenesis.
Megan Clark, a second-year student in Penn Vet, first gained research experience as an undergraduate at the University of Delaware, where she completed a thesis focused on characterizing the immune cells present in the adipose tissue of dairy cows. She has continued to pursue immunology research while at Penn Vet, working in the lab of Phillip Scott, professor of microbiology and immunology in the Department of Pathobiology. There, she has examined the role of T cell metabolism during infection with the parasite Leishmania, which causes a serious skin disease common in the tropics, called leishmaniasis. Recently, the Scott lab found that tissue-resident memory T cells are present not only at the site of Leishmania infection, but also at skin sites distant to infection, where these cells can be retained for up to a year and play a role in protective immunity against the disease. During the fellowship, Clark will build on these findings, using a murine model to examine how these T cells migrate into non-inflamed skin sites, and how they are retained in the skin to provide protection against leishmaniasis.
“This engagement is perhaps the best way for talented students at this stage in their training to understand the powerful opportunity that emerges at the intersection of medicine and laboratory research,” said David J. Asai, senior director in science education at HHMI. “We hope that each of the Med Fellows seriously considers pursuing a career as a physician-scientist.”
For the University of Pennsylvania release, visit here.
Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.
The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.
The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.